Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: chloroquine

January 28, 2026 Pharma applications

Drug Repurposing as an Effective Drug Discovery Strategy

Drug repurposing, or repositioning, has emerged as a pivotal strategy in pharmaceutical research, offering a promising approach to uncover new

Continue reading

June 11, 2021 CD as API / Drug delivery / Pharma applications

Cyclodextrins in the antiviral therapy

This review discusses the basic properties of the different cyclodextrin derivatives, their potential in antiviral formulations, and the prevention and

Continue reading

April 29, 2021 CD as API / Drug delivery / Pharma applications

Targeting Lipid Rafts as a Strategy Against Coronavirus

Lipid rafts are functional membrane microdomains containing sphingolipids, including gangliosides, and cholesterol. These regions are characterized by highly ordered and

Continue reading

August 24, 2020 Drug delivery

A 68-Year-Old Man with Covid-19 and Acute Kidney Injury – Case Records of the Massachusetts General Hospital

The case report discusses the difficulties in the treatment of this patient with acute kidney disease. Acute kidney injury —

Continue reading

May 14, 2020 Pharma applications

Coronavirus and COVID-19: The latest news and views from the scientific community about the new coronavirus and Covid-19

Coronavirus is a family of viruses that cause respiratory infections.The new coronavirus agent was discovered on 12/31/19 after cases registered

Continue reading

Recent Posts

  • Environment-Sensitive Fluorophores Report on Structural Organization of Biological Membranes at Various Depths
  • A Cyclodextrin Surprise in a Japanese Supplement
  • Modifying the interior cavity of cyclodextrin
  • Special issue: Novel macrocycles: from synthesis to supramolecular function
  • Chitosan-coated cyclodextrin-based niosomes enable enhanced nose-to-brain delivery of rivastigmine and asiaticoside for Alzheimer’s disease

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (67)
  • CD as API (347)
  • CD derivatives (411)
  • Cosmetics and toilettry (51)
  • Diagnosis (12)
  • Drug delivery (793)
  • E-ducation (63)
  • Environmental (134)
  • Events (234)
  • Food (223)
  • Gene delivery (20)
  • Household products (4)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (43)
  • Non-pharma applications (401)
  • Other industrial use (106)
  • Pharma applications (1,186)
  • Supramolecular systems (40)
  • Uncategorized (149)

Top Posts

  • A Cyclodextrin Surprise in a Japanese Supplement
  • Modifying the interior cavity of cyclodextrin
  • Chitosan-coated cyclodextrin-based niosomes enable enhanced nose-to-brain delivery of rivastigmine and asiaticoside for Alzheimer's disease
  • Environment-Sensitive Fluorophores Report on Structural Organization of Biological Membranes at Various Depths
  • HPBCD in an approved non-replicating adenoviral vector-based gene therapy product
  • 22nd International Cyclodextrin Symposium (ICS-22) in India
  • How air fresheners work?
  • FDA Grants Approval to HPBCD-Enhanced Biologic: A 'Super-Originator' Formulation
  • New FDA approved medicinal product containing Betadex sulfobutylether sodium: VYKOURA
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,474 other subscribers

Loading Comments...